Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Patel

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
International Journal of Cancer|March 10, 2025
Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiativeNathan Appanna, Rosie Mew, Sophie Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA TrialChung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Integrative multiomics analysis of neointima proliferation in human saphenous vein: implications for bypass graft diseaseDavid Kim, Brandee Goo, Hong Shi, et al.
The New England Journal of Medicine|February 22, 2021
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaRobert Motzer, Boris Alekseev, Sun-Young Rha, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2022
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based studyLennard Y W Lee, Maria C Ionescu, Thomas Starkey, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Scientific Reports|July 25, 2023
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)Thomas Starkey, Maria C Ionescu, Michael Tilby, et al.
G3 (Bethesda, Md.)|November 7, 2019
Expression-Based Cell Lineage Analysis in <i>Drosophila</i> Through a Course-Based Research Experience for Early UndergraduatesJohn M Olson, Cory J Evans, Kathy T Ngo, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
International Journal of Cancer|March 10, 2025
Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiativeNathan Appanna, Rosie Mew, Sophie Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA TrialChung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Integrative multiomics analysis of neointima proliferation in human saphenous vein: implications for bypass graft diseaseDavid Kim, Brandee Goo, Hong Shi, et al.
The New England Journal of Medicine|February 22, 2021
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaRobert Motzer, Boris Alekseev, Sun-Young Rha, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2022
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based studyLennard Y W Lee, Maria C Ionescu, Thomas Starkey, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Scientific Reports|July 25, 2023
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)Thomas Starkey, Maria C Ionescu, Michael Tilby, et al.
G3 (Bethesda, Md.)|November 7, 2019
Expression-Based Cell Lineage Analysis in <i>Drosophila</i> Through a Course-Based Research Experience for Early UndergraduatesJohn M Olson, Cory J Evans, Kathy T Ngo, et al.
Pageof 9